.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Teva
AstraZeneca
Federal Trade Commission
Accenture
Citi
Farmers Insurance
Express Scripts
Colorcon
Boehringer Ingelheim

Generated: September 23, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Summary for Patent: ► Subscribe

Title: Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
Abstract:Disclosed is the use of cloprostenol, fluprostenol, and their pharmaceutically acceptable salts and esters for the treatment of glaucoma and ocular hypertension. Also disclosed are ophthalmic compositions comprising said compounds.
Inventor(s): Bishop; John E. (Arlington, TX), DeSantis, Jr.; Louis (Fort Worth, TX), Sallee; Verney L. (Burleson, TX)
Assignee: Alcon Laboratories, Inc. (Fort Worth, TX)
Application Number:08/101,598
Patent Claim Types:
see list of patent claims
Use; Composition; Compound;

No matches for this query

International Patent Family for Patent: ► Subscribe

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Germany69434228► Subscribe
Canada2129287► Subscribe
Denmark0639563► Subscribe
Denmark1514548► Subscribe
Denmark1920764► Subscribe
European Patent Office0639563► Subscribe
European Patent Office1514548► SubscribeC300671Netherlands► Subscribe
European Patent Office1514548► SubscribePA2014029Lithuania► Subscribe
European Patent Office1514548► SubscribeCA 2014 00038Denmark► Subscribe
European Patent Office1920764► SubscribeCA 2012 00030Denmark► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Chinese Patent Office
Cantor Fitzgerald
Healthtrust
Covington
Fuji
Moodys
Queensland Health
Express Scripts
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot